Skip To Main Content
This website is intended exclusively for healthcare professionals residing and/or working in the UAE.
Campus
  • Payor
Campus
  • Payor

Science at Sanofi

Discover a wide variety of articles, videos, podcasts, accredited courses, applications, conferences and scientific events in different therapeutic areas

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content

New 2022 ADA/EASD Guidelines: GLPP-1 RA/Insulin Combination Is Recommended

ADA/EASD recommend considering combination injectables therapy of basal insulin/GLP-1 RA (Such as Soliqua®) as valuable treatment option to provide adequate efficacy for achieving and maintaining glycemic goals.

Learn more

Inspiring Stories of Patients Living with ASMD

Learn more

What can biologic treatment do for patients with CRS with nasal polyps?

Learn more

Their Stories shaped them like Pearls

Learn more

Post-exercise hypoglycemia in relation to medication regimen among adults with type 2 diabetes

Learn more

What Is Time-in-Range?

Learn more

The Role of Pediatrician in Gaucher Disease

Learn more

ASMD Phenotypes

Learn more

Understanding Time-in-Range: Assessment, Targets, and Benefits for Optimal Glycemic Control

Learn more

Real-world evidence of treatment intensification in people with T2D inadequately controlled on GLP-1 RAs

Learn more

Regulate LDL-C level for those undergoing coronary revascularization (Diabetic Patients)

Learn more

Prophylactic Strategies for VTE in Gynecologic Cancer Patients

Learn more